• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

In vitro evaluation of pooled buffy coat platelets treated with photochemical pathogen inactivation using amotosalen.

作者信息

Cazenave J-P, Aleil B, Wiesel M-L, Laforêt M, Isola H

出版信息

Vox Sang. 2004 Apr;86(3):201-2. doi: 10.1111/j.0042-9007.2004.00417.x.

DOI:10.1111/j.0042-9007.2004.00417.x
PMID:15078258
Abstract
摘要

相似文献

1
In vitro evaluation of pooled buffy coat platelets treated with photochemical pathogen inactivation using amotosalen.
Vox Sang. 2004 Apr;86(3):201-2. doi: 10.1111/j.0042-9007.2004.00417.x.
2
The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates.新型病原体灭活技术对血小板浓缩物的临床和生物学影响。
Blood Rev. 2014 Nov;28(6):235-41. doi: 10.1016/j.blre.2014.07.005. Epub 2014 Aug 24.
3
[Photochemical inactivation of pathogens in platelets and plasma: five years of clinical use in routine and hemovigilance. Towards a change of paradigm in transfusion safety].[血小板和血浆中病原体的光化学灭活：在常规和血液警戒中的五年临床应用。迈向输血安全范式的转变]
Transfus Clin Biol. 2011 Apr;18(2):53-61. doi: 10.1016/j.tracli.2011.02.023. Epub 2011 Apr 6.
4
Pathogen inactivation of double-dose buffy-coat platelet concentrates photochemically treated with amotosalen and UVA light: preservation of in vitro function.经阿莫沙林和紫外线A光光化学处理的双剂量富血小板血浆浓缩物的病原体灭活：体外功能的保存
Vox Sang. 2015 May;108(4):340-9. doi: 10.1111/vox.12232. Epub 2014 Dec 30.
5
Profiling alterations in platelets induced by Amotosalen/UVA pathogen reduction and gamma irradiation--a LC-ESI-MS/MS-based proteomics approach.基于 LC-ESI-MS/MS 的蛋白质组学方法分析 Amotosalen/UVA 病原体减少和γ辐照诱导的血小板变化。
Blood Transfus. 2012 May;10 Suppl 2(Suppl 2):s63-70. doi: 10.2450/2012.010S.
6
Inactivation of Zika virus in platelet components using amotosalen and ultraviolet A illumination.使用氨甲环酸和紫外线A照射对血小板成分中的寨卡病毒进行灭活
Transfusion. 2017 Aug;57(8):2016-2025. doi: 10.1111/trf.14161. Epub 2017 Jul 3.
7
Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial.采用光化学法进行病原体灭活处理的血小板的治疗效果及安全性：SPRINT试验
Blood. 2004 Sep 1;104(5):1534-41. doi: 10.1182/blood-2003-12-4443. Epub 2004 May 11.
8
Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.将血小板的INTERCEPT血液系统应用于常规血库制造程序：单采血小板的评估
Vox Sang. 2004 May;86(4):239-45. doi: 10.1111/j.0042-9007.2004.00419.x.
9
Prevention of transfusion-associated graft-versus-host disease with pathogen-reduced platelets with amotosalen and ultraviolet A light: a review.使用阿莫曲塞林和紫外线A光处理的病原体灭活血小板预防输血相关移植物抗宿主病：综述
Vox Sang. 2017 Oct;112(7):607-613. doi: 10.1111/vox.12558. Epub 2017 Aug 18.
10
Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial.采用光化学病原体灭活处理制备的混合去白细胞血小板成分输血：欧洲SPRITE试验
Blood. 2003 Mar 15;101(6):2426-33. doi: 10.1182/blood-2002-03-0932. Epub 2002 Nov 27.

引用本文的文献

1
Marginal zone B cells are responsible for the production of alloantibodies following platelet transfusion in mice.边缘区 B 细胞负责在小鼠血小板输注后产生同种抗体。
Blood Adv. 2023 Apr 25;7(8):1356-1365. doi: 10.1182/bloodadvances.2022008411.
2
Evaluation of White Blood Cell- and Platelet-Derived Cytokine Accumulation in MIRASOL-PRT-Treated Platelets.MIRASOL光化学修饰血小板治疗中白细胞和血小板衍生细胞因子蓄积的评估
Transfus Med Hemother. 2009;36(2):114-120. doi: 10.1159/000203359. Epub 2009 Mar 4.
3
[Evolution of techniques for preparation of labile blood products (LBP): pathogen inactivation in LBP].
[不稳定血液制品（LBP）制备技术的演变：LBP中的病原体灭活]
Transfus Clin Biol. 2009 May;16(2):179-89. doi: 10.1016/j.tracli.2009.03.022. Epub 2009 May 13.
4
Pathogen inactivation techniques.病原体灭活技术。
Best Pract Res Clin Haematol. 2006;19(1):205-42. doi: 10.1016/j.beha.2005.04.001.